These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7929525)

  • 1. Triglycyl-lysine-vasopressin for reduction of blood loss during wound excision in patients with burns.
    Onarheim H; Aanderud L; Røttingen JT
    J Burn Care Rehabil; 1994; 15(4):392. PubMed ID: 7929525
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of triglycyl-lysine-vasopressin on skin blood flow and blood loss during wound excision in patients with burns.
    Garner WL; Thomson PD; Moore NP; Rodriguez JL; Smith DJ
    J Burn Care Rehabil; 1993; 14(4):458-60. PubMed ID: 8408173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective double blind randomized study comparing the need for blood transfusion with terlipressin or a placebo during early excision and grafting of burns.
    Mzezewa S; Jönsson K; Aberg M; Sjöberg T; Salemark L
    Burns; 2004 May; 30(3):236-40. PubMed ID: 15082350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of blood loss by triglycyl-lysine-vasopressin during early excision of burns in pigs.
    Vernersson E; Jacobsson S; Aberg M
    Scand J Plast Reconstr Surg; 1984; 18(3):291-6. PubMed ID: 6528232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglycyl-lysine-vasopressin or lysine-vasopressin in early excision of burns. An experimental study comparing the effects on blood loss, hemodynamics and renal function.
    Vernersson E; Palmer B; Aberg M
    Scand J Plast Reconstr Surg; 1984; 18(3):285-90. PubMed ID: 6528231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine-vasopressin in excisional treatment of burns in pigs. Decreased blood loss and earlier circulatory recovery.
    Vernersson E; Ahlgren I; Aronsen KF; Palmer B
    Acta Chir Scand; 1983; 149(1):15-22. PubMed ID: 6404083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of hemorrhage during renal failure with triglycyl-lysine-vasopressin.
    Garner WL; Rodriguez JL; Thomson PD; Brosius FC; Smith DJ
    Ann Plast Surg; 1993 Jul; 31(1):78-81. PubMed ID: 8357224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulatory and renal effects of triglycyl-lysine-vasopressin and excision in experimental burns.
    Vernersson E; Aronsen KF; Aberg M
    Eur Surg Res; 1985; 17(4):242-50. PubMed ID: 4043157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of triglycyl-lysine-vasopressin (terlipressin INN, Glypressin) on skin blood flow, measured with laser Doppler flowmetry, thermography and plethysmography. A dose-response study.
    Nilsson G; Lindblom P; Palmer B; Vernersson E; Aberg M
    Scand J Plast Reconstr Surg Hand Surg; 1987; 21(2):149-57. PubMed ID: 2961054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between lysine vasopressin and a long-acting analogue (N alpha-triglycyl-lysine vasopressin) used as local hemostatic agents for conization.
    Rundqvist E; Allen D; Larsson G
    Acta Obstet Gynecol Scand; 1988; 67(4):301-5. PubMed ID: 3051878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hemorrhaging esophageal varices with triglycyl lysine vasopressin. Case reports].
    Caletti GC; Brocchi E; Guizzardi G; Bartolucci C; Zani L; Labo' G
    Recenti Prog Med; 1984 Jun; 75(6):566-73. PubMed ID: 6333056
    [No Abstract]   [Full Text] [Related]  

  • 12. [Haemodynamic effect of triglycyl-lysine vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial].
    Fort E
    Gastroenterol Clin Biol; 1990; 14(11):898-9. PubMed ID: 2276578
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of triglycyl vasopressin in persistent hematuria associated with sickle cell hemoglobin.
    John EG; Schade SG; Spigos DG; Cort JH; Rosenthal IM
    Arch Intern Med; 1980 Dec; 140(12):1589-93. PubMed ID: 7458494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of major blood loss.
    Lange M; Van Aken H; Westphal M
    N Engl J Med; 2007 Sep; 357(12):1260; author reply 1261. PubMed ID: 17891841
    [No Abstract]   [Full Text] [Related]  

  • 15. A simple alternative for preventing the blood loss in burn surgery.
    Ors S
    Burns; 2002 Aug; 28(5):519. PubMed ID: 12163297
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience of immediate burn wound excision and grafting for patients with extensive burns].
    Nakazawa H; Nozaki M
    Nihon Geka Gakkai Zasshi; 2005 Dec; 106(12):745-9. PubMed ID: 16869128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of the vasoconstrictor hemostatic Remestyp in surgical obstetrics].
    Dimitrov A
    Akush Ginekol (Sofiia); 1999; 38(3):58-60. PubMed ID: 10734687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities of reducing blood loss during gynecologic operations with drugs].
    Krizko M
    Ceska Gynekol; 1999 Jun; 64 Suppl 2():7-8. PubMed ID: 10566247
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of a suitable dosage of lysine-vasopressin and triglycyl-lysine-vasopressin, given in a gel-solution locally in the rectum of rats for possible radioprotective purposes.
    Bjelkengren G
    Acta Oncol; 1990; 29(8):1041-6. PubMed ID: 2278725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac function and central circulation in lysine-vasopressin treatment of experimental burns.
    Vernersson E
    Acta Anaesthesiol Scand; 1984 Jun; 28(3):325-30. PubMed ID: 6741449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.